Thank you for your interest in registering for the Summit, offered by AAPP virtually, October 1-2 2026. All purchases after the live event provide home study/enduring credit via session recordings.
Searching for Solutions
No summary available
AAPP recently published a statement of support for plaintiffs in American Academy of Pediatrics et al. v. Kennedy Jr., et al. Login to read the support letter and to see all recent comment letters.
"Pharmacy school taught us how to manage complex pharmacotherapy, but it did not teach us how to budget, navigate major financial decisions, or invest. These are the financial lessons I wish I learned earlier in my career, because even a little awareness from the start can prevent a lot of stress later."
"One of the most important lessons I have learned is that professional development does not depend on having a specific title or years of clinical experience but instead depends on early intention and curiosity."
No summary available
No summary available
No summary available
This blog series by the Resident and New Practitioner Committee is targeted to psychiatric pharmacists seeking their first or a new position. This blog explores opportunities in community health systems.
Pharmacist education includes patient assessment, differential diagnosis, laboratory testing, drug administration and prescribing.
No summary available
The report and webinar examine current approaches to integrating SUD prevention with physical health care at the state level including implementation, financing, partnerships, challenges, and support needs, particularly for adolescents, and where states are in the implementation of services. Expanding access to Preventing substance misuse, abuse, and addiction is one of the core strategic priorities for SAMHSA and aligns closely with the Make America Healthy Again initiative.
This study found that barriers and facilitators to LDI completion were linked to five COM-B model components: physical capability, physical opportunity, social opportunity, reflective motivation, and automatic motivation.
These results suggest that overdose prevention centers are cost-saving upstream interventions to mitigate injection-related infections and hospitalizations.
In this retrospective analysis of a large EHR dataset, they found that following the elimination of the X-waiver, the incidence of new OUD diagnoses declined by 2%, while subsequent buprenorphine initiation increased by 14%.
Unhealthy alcohol use is highly prevalent in the United States, with almost half of all regular consumers reporting binge drinking.
Compared with varenicline alone, combination therapy was associated with statistically significantly higher abstinence rates at the longest follow-up.
The National Council Medical Director Institute (MDI) has released the first-ever standardized performance benchmarks for initiation and continuation of long-acting medications for psychotic disorders, bipolar disorder, opioid use disorder and alcohol use disorder. Past President Jerry McKee represented AAPP on the expert panel while Past President Ray Love contributed as a representative of NASMHPD. Download the MDI report to learn how to implement these benchmarks in your practice.
The helpline is a free, confidential service providing caregiver-led support, tools and strategies, trusted guidance, and connection at every stage of the caregiving journey.
The AAPP Resident and New Practitioner Committee recently completed updates to treatment guidelines and pharmacy essentials. These free resources provide references and clinical pearls for practitioners beginning to practice in psychiatry as well as treatment guidelines for anxiety and related disorders, bipolar disorder, depression, medication-induced movement disorders, schizophrenia, seizure disorders, sleep-wake disorders, and substance use disorder.
No summary available
No summary available
For the fourth time, remote prescribing of controlled substances will be allowed without permanent policy. The Trump administration appears poised to extend a temporary, Covid-era rule allowing health providers to prescribe certain controlled substances, like ADHD medications and treatments for opioid addiction, via telemedicine.
This study's findings have implications for disease classification, precision medicine and clinical practice.
This study examined longer-term health outcomes associated with CM treatment for StUD.